HIGHLIGHTS
- who: Brief Report and collaborators from the Cardiovascular Physiology Core Facility, Department of Medicine, University of Wisconsin-Madison, Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan have published the paper: Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs, in the Journal: Pharmaceuticals 2022, 765 of /2022/
- what: The authors aim to establish a drug toxicity screening platform using 13 human iPSC lines to investigate the toxicity of the current and prospective COVID-19 treatment options, in particular, those with promising outcomes, to determine their potential cardio- and neurotoxicity in humans. The authors only . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.